- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan.
Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work Program from its very own Dan LaVallee, senior director, Social Impact, UPMC Health Plan, and Markisha Jones, a Pathways to Work/Freedom House 2.0 graduate. These programs provide holistic support via social, emotional, and financial initiatives that enable program participants to overcome barriers to employment and find jobs within their communities. At their core, they carry on the legacy of the original Freedom House program, which was formed to bring urgently needed emergency medical services to a racially divided Pittsburgh in the 1960s, and of Dr Peter Safar, known as the “father of CPR,” who spearheaded the program’s EMS training and provided invaluable guidance with the program’s founding.
Listen above or on one of these podcast services:
Disparities in Telehealth Access Undermine Adoption Among Patients With Schizophrenia
January 16th 2025The COVID-19 pandemic accelerated the widespread adoption of telemental health care, and new research indicates significant racial and ethnic disparities in access to this technology among Medicaid beneficiaries with schizophrenia.
Read More
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More
